Perspectives on Biopharmaceutical Financing Vehicles and Value Based Reimbursement in Select European Regions

David Williams
Appalachian State University, US

DOI:https://doi.org/10.5912/jcb1337

Abstract:

Purpose: The present paper’s purpose is to examine the perspectives of stakeholders in the biopharmaceutical industry related to the use of crowdfunding and value-based pricing in the future and why firms pursue an initial public offering. Method: It surveys multiple stakeholders in select regions of 4 European countries.  Results: It finds that stakeholders perceive that crowdfunding will have a slight impact on biopharmaceutical start-up firms in the regions in the future; individuals pursue initial public offerings for both growth and exit strategy reasons; and value-based pricing is perceived by most individuals as having a positive effect in the future on the industry in their region. Conclusions: The present paper has sought to show the perspectives related to financing biopharmaceutical innovations of multiple stakeholders in various regions of 4 European countries. At times, it finds differences in perspectives by region and employment type. For the entrepreneur and regional developer, the findings and implications suggest a need for multiple financial vehicles and that firms undertake an initial public offering for multiple reasons beyond as an exit vehicle for the initial investors.